SUPPORT CANADIANS LIVING WITH CANCER
Treatment of atypical teratoid/rhabdoid tumours
There is no standard treatment for atypical teratoid/rhabdoid tumours (AT/RTs). Because these tumours are usually fast growing, doctors will use a combination of treatments to treat them as aggressively as possible.
Surgery is usually the first treatment offered for AT/RTs. Doctors will try to remove as much of the tumour as possible so that other treatments, such as chemotherapy and radiation therapy, have more effect on the remaining cells.
Chemotherapy is usually given after surgery. AT/RTs are sensitive to chemotherapy. Although it may not completely destroy the cancer, many children have good responses to chemotherapy for a period of time. Several clinical trials are studying the effectiveness of high-dose chemotherapy with stem cell rescue in the treatment of AT/RTs.
Radiation is usually combined with chemotherapy after surgery to treat AT/RTs. However, because most children with AT/RT are very young, radiation may not be used as it can damage developing brain cells.
Recurrent atypical teratoid/rhabdoid tumours
There is no standard treatment for children with recurrent AT/RTs. Doctors may suggest the child enrol in a clinical trial.
My favourite thing about Camp Goodtime is being able to hang out with other kids who have survived cancer. They know what is going on in your life and can help you get through it.
Clinical trial discovery improves quality of life
A clinical trial led by the Society’s NCIC Clinical Trials group found that men with prostate cancer who are treated with intermittent courses of hormone therapy live as long as those receiving continuous therapy.